SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-050616
Filing Date
2023-11-01
Accepted
2023-11-01 06:15:26
Documents
1
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5758
  Complete submission text file 0001140361-23-050616.txt   7120
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 650-266-8674
GYRE THERAPEUTICS, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
USMAN NASSIM (Reporting) CIK: 0001206872 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 231366445